Øystein Tveiten retweeted
Important clinical considerations surrounding bone conduction implant use in patients with chronic otitis or #vestibularschwannoma. Great job @AshleyNassiri! @MayoRadiology @MayoClinicENT @MayoClinicNeuro
pubmed.ncbi.nlm.nih.gov/3758…
Øystein Tveiten retweeted
🎙 preoperative SRS has a favorable risk-benefit profile and deserves a pH3 trial❗️@OncoAlert @JAMAOnc
📌Multi🏥cohort
- 👥w/ BMs treated between 2005-2021
- Pre🔪SRS: Median dose 15 Gy or 24 Gy, delivered 2 days pre🔪
🥇🎯: LR, meningeal diissemination (MD), radionecrosis &OS
📊RESULTs
- 404 👥/416 lesions 🔪
- 2-ycavity LR: 13.7% (Factors🔄Systemic status, resection extent, surgery type, tumor type)
- 2-y MD: 5.8% (Factors🔄Resection extent, tumor type)
- 2-y ARE: 7.4% (Factors🔄Margin expansion, melanoma)
- Median OS: 17.2 m
#radonc #surgey #neurooncology
Øystein Tveiten retweeted
Acoustic neuromas, also called vestibular schwannoma, are benign, slow-growing tumors that can affect hearing and balance. We join @ANAssociation to help sponsor #ANAwarenessWeek2023. Learn more about #acousticneuroma in our Health Topics Library at bit.ly/PE_Acoustic.
Øystein Tveiten retweeted
HOT OFF THE PRESS! New disease specific quality of life instrument for #vestibularschwannoma #acousticneuroma @MayoClinicENT @MayoClinicNeuro @ANAssociation
thejns.org/downloadpdf/journ…
Øystein Tveiten retweeted
📍The V-REX randomized clinical trial
➡️ small & medium-sized vestibular schwannoma
➡️diagnosed < 6 months
➡️ 100 patients
👉at 4 years : ✨upfront radiosurgery✨more effective at reducing tumor volume than wait & scan approach
@OncoAlert #OncoAlertAF
jamanetwork.com/journals/jam…
Øystein Tveiten retweeted
“Among patients with newly diagnosed small- and medium-sized vestibular schwannoma, upfront radiosurgery demonstrated a significantly greater tumor volume reduction at 4 years than a wait-and-scan approach with treatment upon tumor growth”-JAMA #gammaknife jamanetwork.com/journals/jam…
Øystein Tveiten retweeted
Among patients with small or medium vestibular schwannoma, a treatment strategy consisting of upfront radiosurgery was more effective at reducing tumor volume at 4 years than was the initial wait-and-scan approach. ja.ma/45eNjqf
Øystein Tveiten retweeted
In a trial conducted in Norway, decompression surgery alone was noninferior to decompression with instrumented fusion. nej.md/2VcGOWk
Øystein Tveiten retweeted
Unfair Warfare Now Recruiting! Looking for TH13s with league experience & experienced base builders to work with our base building team.
Come join our discord server discord.gg/6rcxDBZ or DM @Ristey3 to discuss joining the UW team. Good Luck.
Øystein Tveiten retweeted
#OnlineFirst: Fatigue in patients with #vestibular #schwannoma from 🇳🇴
#Neurosurgery #nsgy #skullbase #ActaNeuro
link.springer.com/article/10…
Øystein Tveiten retweeted
Official announcement is here! dock.io public sale will be Feb. 21, whitelist opens Feb. 8.
Huge thank you to the incredible support we've received from our growing community. Join the conversation: t.me/dockio
medium.com/dock-io/dock-toke…
Øystein Tveiten retweeted
Just told the Prime Minister of #Norway @realDonaldTrump wanted her citizens to move to a country without healthcare or gun control.😂
Øystein Tveiten retweeted
Jeg fik knall i padden af at se VM i enkeltstart i dag. Flot første halvdel af VM i Bergen. #knallipadden
Øystein Tveiten retweeted
Patient versus physician-reported facial disability in vestibular schwannoma: an international cross-sectional study
thejns.org/doi/abs/10.3171/2…
Øystein Tveiten retweeted
The Leksell #GammaKnife supplement has been published. All articles are freely accessible.
thejns.org/toc/sup/125/Suppl…
Øystein Tveiten retweeted
#OnlineFirst Pretreatment growth rate as a predictor of tumor control after radiosurgery for vestibular schwannoma
thejns.org/doi/abs/10.3171/2…
Regardsless initial treatment, long-term facial nerve outcome is good. #schwannoma #gammaknife #neurosurgery thejns.org/doi/abs/10.3171/2…



























